67 - COVID-19 and Transplantation: Where are We Now?

Friday, October 1, 2021

10:00 AM - 11:15 AM EDT

Moderator(s)

Raymund Razonable, MD

Professor of Medicine
Mayo Clinic, MN, United States

Gilead (Individual(s) Involved: Self): Grant/Research Support; Novartis (Individual(s) Involved: Self): DSMB; Regeneron (Individual(s) Involved: Self): Grant/Research Support; Roche/Genentech (Individual(s) Involved: Self): Grant/Research Support
Steven Pergam, MD, MPH

Associate Professor
Fred Hutchinson Cancer Research Center; University of Washington
Seattle, WA, United States

Chimerix (Individual(s) Involved: Self): Clinical Trial; Global Life Technologies, Inc (Individual(s) Involved: Self): Research Grant or Support; Merck & Co. (Individual(s) Involved: Self): Scientific Research Study Investigator; Sanofi Aventis (Individual(s) Involved: Self): Other Financial or Material Support, Provided vaccines for clinical trial sponsored by the NIH

Speaker(s)

Robin Avery, MD

Professor of Medicine
Johns Hopkins
Baltimore, Maryland, United States

AiCuris (Individual(s) Involved: Self): Scientific Research Study Investigator; Astellas (Individual(s) Involved: Self): Scientific Research Study Investigator; chimerix (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck and Co. (Individual(s) Involved: Self): Grant/Research Support, Scientific Research Study Investigator; Oxford Immunotec (Individual(s) Involved: Self): Scientific Research Study Investigator; Qiagen (Individual(s) Involved: Self): Scientific Research Study Investigator; Takeda (Individual(s) Involved: Self): Grant/Research Support
Lara Danziger-Isakov, MD, MPH

Professor
Cincinnati Children's Hospital Medical Center
Cincinnati, OH, United States

Ansun (Individual(s) Involved: Self): Scientific Research Study Investigator; Astellas (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Pfizer (Individual(s) Involved: Self): Scientific Research Study Investigator; Shire (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Viracor: Grant/Research Support
Monica Fung, MD, MPH

Assistant Professor, Infectious Diseases
University of California San Francisco
San Francisco, CA, United States

Novartis (Individual(s) Involved: Self): Scientific Research Study Investigator

Participants should be aware of the following financial/non-financial relationships:

Raymund Razonable, MD: Gilead (Individual(s) Involved: Self): Grant/Research Support; Novartis (Individual(s) Involved: Self): DSMB; Regeneron (Individual(s) Involved: Self): Grant/Research Support; Roche/Genentech (Individual(s) Involved: Self): Grant/Research Support

Steven A. Pergam, MD, MPH: Chimerix (Individual(s) Involved: Self): Clinical Trial; Global Life Technologies, Inc (Individual(s) Involved: Self): Research Grant or Support; Merck & Co. (Individual(s) Involved: Self): Scientific Research Study Investigator; Sanofi Aventis (Individual(s) Involved: Self): Other Financial or Material Support, Provided vaccines for clinical trial sponsored by the NIH

Robin K. Avery, MD: AiCuris (Individual(s) Involved: Self): Scientific Research Study Investigator; Astellas (Individual(s) Involved: Self): Scientific Research Study Investigator; chimerix (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck and Co. (Individual(s) Involved: Self): Grant/Research Support, Scientific Research Study Investigator; Oxford Immunotec (Individual(s) Involved: Self): Scientific Research Study Investigator; Qiagen (Individual(s) Involved: Self): Scientific Research Study Investigator; Takeda (Individual(s) Involved: Self): Grant/Research Support

Lara Danziger-Isakov, MD, MPH: Ansun (Individual(s) Involved: Self): Scientific Research Study Investigator; Astellas (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Pfizer (Individual(s) Involved: Self): Scientific Research Study Investigator; Shire (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Viracor: Grant/Research Support

Monica Fung, MD, MPH: Novartis (Individual(s) Involved: Self): Scientific Research Study Investigator

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the unique screening and prevention strategies for dealing with transplant donors and recipients
discuss approved treatment approaches and emerging therapies for transplant patients with COVID-19
summarize current recommendations for SARS-CoV-2 vaccination among different transplant populations

Presentations:

COVID-19 Vaccination of SOT and HSCT Recipients
Speaker: Robin K. Avery, MD – Johns Hopkins
Screening of SOT and HSCT Donors and Candidates Prior to Transplantation
Speaker: Lara Danziger-Isakov, MD, MPH – Cincinnati Children's Hospital Medical Center
Treatment of COVID-19 Infected Transplant and Immunosuppressed Patients
Speaker: Monica Fung, MD, MPH – University of California San Francisco